4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-21-004002
PRES./CHIEF SCIENTIFIC OFFICER bought 3,750 shares at $2.73 ($10,238)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2021-08-17 | Purchase | +3,750 | $2.73 | $10,238 | 34,641 | I |
| Open-market purchases · 3,750 sh · avg $2.73 · $10,238 | |||||||
Loading xslF345X03/form4-08182021_030825.xml…